dapagliflozin
astrazeneca
['dapa-hf']
in #dapa-hf: higher gdf-15 associated with risk of whf or cv death and may identify pts who derive greater absolute benefit from sglt2i #acc23 
Providing the latest news and research from the TIMI Study Group, an ARO affiliated with Brigham and Women’s Hospital and Harvard Medical School.